BioScience Health Innovations (BHIC) Total Debt (2019 - 2022)

BioScience Health Innovations (BHIC) has 4 years of Total Debt data on file, last reported at $2893.0 in Q2 2022.

• Total Debt for Q2 2022 came in at $2893.0, down 82.47% year-over-year; the trailing twelve-month figure through May 2022 was $2893.0 (down 82.47% YoY), and the FY2021 annual result was $17426.0, up 123.1% from the prior year.
• Total Debt retreated to $2893.0 in Q2 2022 per BHIC's latest filing, from $17426.0 in the prior quarter.
• Over five years, Total Debt peaked at $17426.0 in Q3 2021 and troughed at $2893.0 in Q2 2022.
• A 4-year average of $10899.3 and a median of $10956.5 in 2020 frame the typical range for Total Debt.
• The sharpest annual moves came in 2021 and 2022: Total Debt jumped 157.8% in 2021, then sank 82.47% in 2022.
• A 4-year view of Total Debt shows it stood at $6115.0 in 2019, then jumped by 130.61% to $14102.0 in 2020, then climbed by 23.57% to $17426.0 in 2021, then tumbled by 83.4% to $2893.0 in 2022.
• Business Quant data shows BHIC's Total Debt at $2893.0 in Q2 2022, $17426.0 in Q4 2021, and $17426.0 in Q3 2021.